Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes

(2014) Ohad Benjamini et al.   LEUKEMIA & LYMPHOMA

Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study

(2011) J A Royle et al.   BRITISH JOURNAL OF CANCER

Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia

(2010) Anders Mellemgaard et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype

(2010) Lindsay M. Morton et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemoimmunotherapy of chronic lymphocytic leukemia

(2010) Constantine S. Tam et al.   Nature Reviews Clinical Oncology

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience

(2009) P. Abrisqueta et al.   BLOOD

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma

(2009) V Koljonen et al.   BRITISH JOURNAL OF CANCER

Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia

(2009) J. R. Toro et al.   HAEMATOLOGICA

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

(2008) Apostolia-Maria Tsimberidou et al.   JOURNAL OF CLINICAL ONCOLOGY